Get started
Author

Sarah Abbas

Observed name: SARAH ABBAS
ORCID: 0000-0002-3278-9240
Observed ORCID: 0000-0002-3278-9240
OpenAlex ID: A5063259950
Neuropsychiatric Symptoms and Microglial Activation in Patients with Alzheimer Disease
2023 · Cristiano Schaffer Aguzzoli, Pâmela C. L. Ferreira, et al. · JAMA Network Open · 52
PDF
Glial reactivity correlates with synaptic dysfunction across aging and Alzheimer’s disease
2025 · Francieli Rohden, Pamela C. L. Ferreira, et al. · Nature Communications · 32
PDF
CSF total tau as a proxy of synaptic degeneration
2025 · Carolina Soares, Bruna Bellaver, et al. · Nature Communications · 15
PDF
Utility of plasma GFAP as a secondary endpoint for clinical trials in Alzheimer’s disease
2025 · Sarah Abbas, Pamela C. L Ferreira, et al. · The Journal of Prevention of Alzheimer s Disease · 14
Impact of the polygenic risk scores for attention‐deficit/hyperactivity disorder in Alzheimer's disease
2025 · Douglas T. Leffa, Guilherme Povala, et al. · Alzheimer s & Dementia · 9
PDF
Sex impacts the association of plasma Glial Fibrillary Acidic Protein with neurodegeneration in Alzheimer’s disease
2023 · Sarah Abbas, Bruna Bellaver, et al. · Alzheimer s & Dementia · 6
PDF
Performance of an AI‐based prediction model versus stratified thresholds using plasma biomarkers for biological staging of AD
2024 · Marina Scop Madeiros, Pamela C.L. Ferreira, et al. · Alzheimer s & Dementia · 2
PDF
Sex modulates the role of astrocyte reactivity in preclinical Alzheimer’s disease
2023 · Bruna Bellaver, Guilherme Povala, et al. · Alzheimer s & Dementia · 2
PDF
Vascular pathology drives the association of plasma GFAP with gray matter atrophy and cognitive decline in amyloid‐negative individuals
2025 · Markley Silva Oliveira, Matheus Scarpatto Rodrigues, et al. · Alzheimer s & Dementia · 1
PDF
Tau exacerbates the development of distinct neuropsychiatric symptoms in late braak stage – the head study
2024 · Cristiano Schaffer Aguzzoli, Guilherme Povala, et al. · Alzheimer s & Dementia · 1
PDF
Plasma high‐density lipoprotein levels is associated with preserved hippocampal volume in Alzheimer`s disease individuals without vascular co‐pathology
2024 · Matheus Scarpatto Rodrigues, Markley Silva Oliveira, et al. · Alzheimer s & Dementia · 1
PDF
Utility of plasma p‐tau217 as a secondary outcome for clinical trials across AD continuum
2024 · Pamela C.L. Ferreira, Bruna Bellaver, et al. · Alzheimer s & Dementia · 1
PDF
Exploring the utility of Plasma GFAP as a secondary endpoint in Alzheimer's disease Clinical trials to monitor disease progression
2024 · Sarah Abbas, Pamela C.L. Ferreira, et al. · Alzheimer s & Dementia · 1
PDF
Hippocampal degeneration is associated with GFAP levels in individuals with vascular dementia independently of amyloidosis
2024 · Markley Oliveira, Bruna Bellaver, et al. · Alzheimer s & Dementia · 1
PDF
Alzheimer's disease staging with [18F]MK6240 and [18F]Flortaucipir ‐ the HEAD study
2024 · Carolina Soares, Guilherme Povala, et al. · Alzheimer s & Dementia · 1
PDF
CSF total tau is more closely associated with synaptic dysfunction than overt neurodegeneration
2023 · Carolina Soares, Bruna Bellaver, et al. · Alzheimer s & Dementia · 1
PDF
Synaptic dysfunction, Tau pathology and Neurodegeneration
2023 · Carolina Soares, Bruna Bellaver, et al. · Alzheimer s & Dementia · 1
PDF
Plasma p‐tau and brain‐derived total tau biomarkers predict longitudinal changes in Aβ, tau, and cognition across the AD continuum
2023 · Pamela C.L. Ferreira, Bruna Bellaver, et al. · Alzheimer s & Dementia · 1
PDF
Astrocyte reactivity is associated with synaptic dysfunction across the aging and Alzheimer’s disease spectrum, whereas microglial reactivity is specifically associated with synaptic dysfunction related to cognitive impairment
2023 · Francieli Rohden, Pamela C.L. Ferreira, et al. · Alzheimer s & Dementia · 1
PDF
Increased Genetic Risk for ADHD Potentiates Cognitive Impairment and Brain Hypometabolism in Alzheimer’s Disease Patients
2023 · Douglas Teixeira Leffa, Guilherme Povala, et al. · Alzheimer s & Dementia · 1
PDF
Architectural Heritage Recognition with Deep Learning: An ANN and CNN Approach
2026 · MAJID ALI BAIG, SARAH ABBAS · Research Square
Association Between Plasma GFAP and Medial Temporal Atrophy and Cognition in Amyloid-Negative Cerebrovascular Disease
2026 · Markley Silva Oliveira-Junior, Matheus Scarpatto Rodrigues, et al. · Neurology
Robust Symptomatic Subtypes of Typical Alzheimer’s Disease Characterized by Differential Neuropathological Patterns and Functional Decline
2024 · Hussein Zalzale, Pamela C.L. Ferreira, et al. · Alzheimer s & Dementia
PDF
Evaluating Congruence Between Clinical and Biological Staging Across The Alzheimer’s Disease Spectrum
2024 · Hussein Zalzale, Marina Scop Madeiros, et al. · Alzheimer s & Dementia
PDF
Attention‐deficit/hyperactivity disorder impacts the development of neuropsychiatric symptoms in Alzheimer’s disease
2024 · Douglas Teixeira Leffa, Bruna Bellaver, et al. · Alzheimer s & Dementia
PDF
Works count: 55
Citation count: 142
H-index: 6
I10-index: 4
Year
Topic
Type